Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 27, 2022 - Issue 3
Submit an article Journal homepage
168
Views
2
CrossRef citations to date
0
Altmetric
Review

Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer

Helena Botea Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain;b H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octbure (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, SpainView further author information
,
Andrés Mesasc Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, SpainView further author information
,
Javier Baenaa Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain;b H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octbure (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, SpainView further author information
,
Mercedes Herreraa Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain;b H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octbure (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, SpainView further author information
&
Luis Paz-Aresa Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain;b H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octbure (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain;d CIBERONC, Madrid, Spain;e Department of Medicine, Complutense University, Madrid, SpainCorrespondence[email protected]
View further author information
Pages 289-300 | Received 03 Mar 2022, Accepted 11 Aug 2022, Published online: 06 Oct 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yuandi Wang, Lijuan Xing, Lexiu Deng, Xinsheng Wang, Dandan Xu, Bu Wang & Zhihua Zhang. (2023) Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer. International Journal of General Medicine 16, pages 997-1015.
Read now

Articles from other publishers (1)

Man Wang, Lijie Zhu, Xiaoxu Yang, Jiahui Li, Yu’e Liu & Ying Tang. (2023) Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer. Frontiers in Pharmacology 14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.